Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes.

Gomez-Peralta, Fernando; Abreu, Cristina; Lecube, Albert; Bellido, Diego; Soto, Alfonso; Morales, Cristóbal; Brito-Sanfiel, Miguel; Umpierrez, Guillermo

Gomez-Peralta, Fernando; Abreu, Cristina; Lecube, Albert; Bellido, Diego; Soto, Alfonso; Morales, Cristóbal; Brito-Sanfiel, Miguel; Umpierrez, Guillermo.

Afiliação

Gomez-Peralta F; Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain. fgomezp@saludcastillayleon.org.
Abreu C; Endocrinology and Nutrition Unit, Segovia General Hospital, Segovia, Spain.
Lecube A; Endocrinology and Nutrition Unit, Hospital Universitari Arnau de Vilanova de Lleida, Institut de Recerca Biomèdica de Lleida, CIBERDEM (CIBER de Diabetes y Enfermedades Metabólicas Asociadas, ISCIII), University of Lleida, Lleida, Spain.
Bellido D; Endocrinology and Nutrition Section, Hospital Marcide, Ferrol, Spain.
Soto A; Endocrinology and Nutrition Department, Hospital de La Coruña, A Coruña, Spain.
Morales C; Endocrinology and Nutrition Department, Virgen Macarena Hospital, Seville, Spain.
Brito-Sanfiel M; Endocrinology and Nutrition Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.
Umpierrez G; Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.

Diabetes Ther ; 8(5): 953-962, 2017 Oct.

Article em En | MEDLINE | ID: mdl-28721687

Palavras-chave

Concomitant; Initiation; Management; SGLT2 inhibitors; Type 2 diabetes

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Diabetes Ther Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha